A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell carcinoma, a type of kidney cancer.

EXEL rides on strong Cabometyx demand in RCC and NET, but Q2 sales miss and rising competition cloud the outlook.

During a live event, Sumanta K. Pal, MD, discussed lenvatinib dosing and tivozanib efficacy for patients with metastatic ...

Adding casdatifan to Cabometyx therapy showed encouraging activity and was generally well tolerated in previously treated ...

Kidney cancer risks, symptoms, treatment, and prevention, including the benefits of robotic-assisted surgery for optimal ...

James Whale, a longtime radio and television host from Britain, has died at age 74. His death was announced on August 4, 2025 ...

HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a ...